newsfilter
← Latest News
GlobeNewswire·

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026

DURHAM, N.C., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE:PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs